Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Particle Size Distribution in Powders

Posted on By

SOP for Particle Size Distribution in Powders

Standard Operating Procedure for Particle Size Distribution in Powders

1) Purpose

The purpose of this SOP is to outline the procedure for determining the particle size distribution of powder formulations in the pharmaceutical industry to ensure uniformity and quality.

2) Scope

This SOP applies to all personnel involved in particle size distribution testing of powder formulations within the pharmaceutical quality control (QC) department.

3) Responsibilities

Analytical Chemist: Responsible for performing particle size distribution testing and documenting results.
Quality Assurance (QA) Department: Responsible for reviewing and approving the particle size distribution testing procedure and results.

See also  SOP for Blend Uniformity Testing in Powders

4) Procedure

  1. Sample Preparation:
    1. Select a representative sample of the powder formulation according to sampling plan.
    2. Follow preparation methods that do not alter the particle size distribution.
  2. Instrument Setup:
    1. Calibrate the particle size analyzer using calibration standards appropriate for the particle size range.
    2. Ensure the instrument is clean and free from any contaminants.
  3. Testing:
    1. Introduce the prepared sample into the particle size analyzer following manufacturer instructions.
    2. Run the analysis to obtain particle size distribution data.
  4. Data Analysis:
    1. Analyze the data obtained from the particle size analyzer to determine the distribution of particle sizes.
    2. Calculate parameters such as D10, D50 (median), and D90 to characterize the particle size distribution.
  5. Reporting:
    1. Prepare a particle size distribution report summarizing the procedure, results, calculations, and
conclusions.
  • Submit the report to the QA department for review and approval.
  • Documentation:
    1. Maintain accurate records of all particle size distribution testing activities, including raw data, calculations, and reports.
    2. File documentation in accordance with Good Documentation Practices (GDP).
  • 5) Abbreviations, if any

    SOP: Standard Operating Procedure
    QC: Quality Control
    QA: Quality Assurance
    D10, D50, D90: Particle size distribution parameters
    GDP: Good Documentation Practices

    6) Documents, if any

    Particle Size Distribution Testing Protocol, Test Results, Particle Size Distribution Report

    7) Reference, if any

    Pharmacopeial guidelines for particle size distribution testing.

    8) SOP Version

    Version 1.0

    See also  Powder & Granules: SOP for Stability Testing of Granules
    Powder & Granules Tags:analytical method development granules, assay of active ingredient granules, bulk density testing granules, contamination prevention powder, documentation in powder manufacturing, equipment cleaning for powders, final product inspection powder, flowability testing powders, formulation development granules, granulation stability testing, granule calibration SOP, granule production procedure, granule quality control SOP, homogeneity testing granules, in-process testing granules, microbial testing powder, particle size distribution powders, pharmaceutical powder handling, powder blending protocol, powder manufacturing SOP, powder packaging guidelines, powder storage conditions, process optimization powders, process validation powders, raw material inspection powders, sample collection for powders, SOP for granulation techniques, sterility in granule production, training SOP for granule production, waste disposal in granule production

    Post navigation

    Previous Post: SOP for Ointment Homogenizer
    Next Post: SOP for Pharmacovigilance Signal Evaluation and Prioritization

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version